封面
市場調查報告書
商品編碼
1698450

肺支架市場:2025-2030 年預測

Lung Stent Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計 2025 年肺支架市場價值將達到 1.5632 億美元,到 2030 年將達到 2.02422 億美元,複合年成長率為 5.3%。

肺支架是一種放置於患者氣道中的中空管。肺支架有助於打開呼吸系統的狹窄區域。主要用於治療呼吸道和肺部疾病以及氣喘、中樞呼吸道阻塞、慢性阻塞性肺病、青光眼和肺癌等慢性疾病。不規則肉芽組織、肺癌、轉移性惡性腫瘤、感染疾病、結核病、淋巴瘤和其他發炎性疾病也會引起氣道變窄或狹窄。在大多數情況下,氣管支氣管(氣道)支架是一種用於打開狹窄氣道的裝置。支架技術的創新也是預估期內推動肺支架市場成長的因素之一。同樣,醫療技術法規環境的變化預計也將推動肺支架的需求。

市場趨勢:

  • 肺癌盛行率上升:全球肺癌患者數量的增加是預測期內推動肺支架市場成長的主要因素。肺支架用於打通肺癌患者阻塞的氣道,解決了一個關鍵需求。在全球範圍內,近年來肺癌患者數量大幅增加。例如,加拿大癌症協會預測,到2023年,加拿大肺癌患者數量將從15,800人增加到17,300人,凸顯了肺支架的需求不斷成長。
  • 老齡人口的增加:全球老年人口的增加也是推動肺支架市場發展的關鍵因素。隨著老年人口的增加,對肺支架的需求明顯增加,以維持呼吸道通暢性並緩解呼吸窘迫,進一步推動了市場擴張。
  • 支架技術的創新:3D 列印等支架技術的進步使得客製化肺支架的創建成為可能。
  • 北美市場主導地位:由於醫療技術的快速進步,北美預計將佔據全球肺支架市場的巨大佔有率。該地區在醫療保健領域採用 3D 列印等最尖端科技方面處於領先地位。此外,旨在改善醫療保健基礎設施的政府措施和政策預計將進一步推動該地區的市場成長。

報告中介紹的主要企業包括波士頓科學公司、Novatech SA、波士頓醫療產品公司、富士系統公司、庫克集團、Hood、E.Benson Laboratories, Inc.、Merit Medical Systems、Taewoong(奧林巴斯全球)、南京微創醫療技術有限公司、S&G Biotech、Stening、微創醫療科學公司、Thoracent Inc. 和 AMET。

本報告的主要優點

  • 深刻分析:獲得涵蓋主要地區和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局:了解全球主要企業所採用的策略策略,並了解正確策略帶來的潛在市場滲透。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
  • 可行的建議:利用洞察力進行策略決策,在動態環境中開闢新的業務流和收益。
  • 受眾廣泛:對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途?

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 各細分市場和地區(包括國家)的收益成長和預測分析
  • 公司概況(策略、產品、財務資訊、主要趨勢等)

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 研究範圍
  • 市場區隔

第3章 商業景氣

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章 肺支架市場(按類型)

  • 介紹
  • 支氣管支架
  • 喉支架

6. 肺支架市場(依產品類型)

  • 介紹
  • 自膨脹
  • 球囊擴張型
  • 非擴展

第7章肺支架市場-依產品分類的材料

  • 介紹
  • 金屬
    • 鎳鈦合金
    • 不銹鋼
    • 其他
  • 矽膠
  • 混合

8. 肺支架市場(依最終用戶)

  • 介紹
  • 醫院
  • 門診手術中心
  • 其他

9. 肺支架市場(按地區)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 台灣
    • 其他

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第11章 公司簡介

  • Boston Scientific Corporation
  • Novatech SA
  • Boston Medical Products, Inc.
  • Fuji Systems Corporation
  • Cook Group
  • Hood, E.Benson Laboratories, Inc.
  • Merit Medical Systems
  • Taewoong(Olympus Global)
  • Micro-Tech(Nanjing)Co., Ltd.
  • S&G Biotech
  • Stening
  • MicroPort Scientific Corporation
  • Thoracent, Inc.
  • AMETEK Inc.

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061613777

The lung stent market is estimated at US$156.320 million in 2025 and is expected to grow at a CAGR of 5.3% to attain US$202.422 million in 2030.

A lung stent is a type of hollow tube placed through the patient's airway. The lung stent helps in opening the narrowed area in the respiratory system. It is primarily used to treat airway and lung diseases, as well as chronic conditions such as asthma, central airway obstruction, chronic obstructive pulmonary disease, glaucoma, and lung cancer, among others. Irregular granulation tissue, lung cancer, metastatic malignancies, infections, TB, lymphoma, or other inflammatory illnesses can also cause narrowed or stenotic air passages. In most cases, tracheobronchial (airway) stents are devices that are used to splint narrowed airways open. The innovations of the stent technology are also among the factors propelling the lung stent market's growth during the estimated timeline. Similarly, the changing regulatory environment for medical technology is also estimated to boost the demand for lung stents.

Market Trends:

  • Rising incidence of lung cancer: The growing number of lung cancer cases worldwide is a major driver of the lung stent market's growth during the forecast period. Lung stents are used to open blocked airways in lung cancer patients, addressing a critical need. Globally, lung cancer cases have risen significantly in recent years. For instance, the Canadian Cancer Society projects that lung cancer cases in Canada will increase from 15,800 in 2023 to 17,300, highlighting the escalating demand for lung stents.
  • Aging population growth: The increasing global elderly population is another key factor driving the lung stent market. As the older population grows, the need for lung stents to maintain airway patency and relieve respiratory distress becomes more pronounced, further fueling market expansion.
  • Innovations in stent technology: Advances in stent technologies, such as 3D printing, are enabling the creation of customized lung stents. These innovations provide more effective solutions and enhance patient satisfaction, contributing to the market's growth.
  • North America's market dominance: North America is expected to capture a significant share of the global lung stent market due to its rapid advancements in medical technologies. The region is a leader in adopting cutting-edge technologies like 3D printing in healthcare. Additionally, government initiatives and policies aimed at improving healthcare infrastructure are expected to further boost market growth in the region.

Some of the major players covered in this report include Boston Scientific Corporation, Novatech SA, Boston Medical Products, Inc., Fuji Systems Corporation, Cook Group, Hood, E.Benson Laboratories, Inc., Merit Medical Systems, Taewoong (Olympus Global), Micro-Tech (Nanjing) Co., Ltd., S&G Biotech, Stening, MicroPort Scientific Corporation, Thoracent, Inc., and AMETEK Inc. among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Lung Stent Market is analyzed into the following segments:

By Type

  • Tracheobronchial Stents
  • Laryngeal Stents

By Product Type

  • Self-expandable
  • Balloon-expandable
  • Non-expandable

By Product Material

  • Metal
  • Nitinol
  • Stainless Steel
  • Others
  • Silicone
  • Hybrid

By End-User

  • Hospitals
  • Ambulatory Surgery Center
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LUNG STENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Tracheobronchial Stents
  • 5.3. Laryngeal Stents

6. LUNG STENT MARKET BY PRODUCT TYPE

  • 6.1. Introduction
  • 6.2. Self-expandable
  • 6.3. Balloon-expandable
  • 6.4. Non-expandable

7. LUNG STENT MARKET BY PRODUCT MATERIAL

  • 7.1. Introduction
  • 7.2. Metal
    • 7.2.1. Nitinol
    • 7.2.2. Stainless Steel
    • 7.2.3. Others
  • 7.3. Silicone
  • 7.4. Hybrid

8. LUNG STENT MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Ambulatory Surgery Center
  • 8.4. Others

9. LUNG STENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Type
    • 9.2.2. By Product Type
    • 9.2.3. By Product Material
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Type
    • 9.3.2. By Product Type
    • 9.3.3. By Product Material
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Type
    • 9.4.2. By Product Type
    • 9.4.3. By Product Material
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Type
    • 9.5.2. By Product Type
    • 9.5.3. By Product Material
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Type
    • 9.6.2. By Product Type
    • 9.6.3. By Product Material
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Boston Scientific Corporation
  • 11.2. Novatech SA
  • 11.3. Boston Medical Products, Inc.
  • 11.4. Fuji Systems Corporation
  • 11.5. Cook Group
  • 11.6. Hood, E.Benson Laboratories, Inc.
  • 11.7. Merit Medical Systems
  • 11.8. Taewoong (Olympus Global)
  • 11.9. Micro-Tech (Nanjing) Co., Ltd.
  • 11.10. S&G Biotech
  • 11.11. Stening
  • 11.12. MicroPort Scientific Corporation
  • 11.13. Thoracent, Inc.
  • 11.14. AMETEK Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations